Le Lézard
Classified in: Health, Covid-19 virus
Subjects: CALENDAR OF EVENTS, LIFESTYLE, MISCELLANEOUS

8th Canadian Obesity Summit


EDMONTON, Alberta, April 13, 2023 (GLOBE NEWSWIRE) -- 8th Canadian Obesity Summit 

ATTENTION: Editors/producers/journalists covering obesity, health, public health, weight bias and discrimination, nutrition, exercise, healthcare, bariatric medicine, maternal and pregnancy health, social justice, social equity, research, and science.

WHAT: Obesity Canada will host the 8th Canadian Obesity Summit, a biennial conference that brings together healthcare professionals, researchers, policy makers and students working in obesity prevention and management for a collegial, engaging learning experience.

WHEN/WHERE: The conference will be hosted May 14th-17th, 2023 in-person in Whistler, British Columbia at the Fairmont Château Whistler.

FEATURING:

View the 2023 program here.

To register for the Summit click here

Obesity Canada will also be announcing the award winners for the first ever Canadian Obesity Fellowship. The two award winners will provide a 20 minute presentation at the Summit.

About Obesity Canada
Obesity Canada-Obésité Canada is Canada's authoritative voice on evidence-based approaches for obesity prevention, treatment, and policy. Our mission is to improve the lives of Canadians affected by obesity through the advancement of anti-discrimination, prevention, and treatment efforts. www.obesitycanada.ca



These press releases may also interest you

at 00:25
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...

19 mai 2024
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

19 mai 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

19 mai 2024
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

19 mai 2024
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...



News published on and distributed by: